CN
Pipeline
Developing Products
That Are Potent, Enabling,
Novel and Safe
Exosome

Product

Indication

Drug
Discovery

Pre-clinical

IND

Phase I

Phase II

Phase III

BLA

Commer-cialization

MVR-EX105

MVR-EX104

MVR-EX101

MVR-EX107

MVR-EX109

MVR-EX Series

MVR-EX Series

MVR-EX Series

MVR-EX103

Localized Adipose
Metabolic Remodeling

Alopecia

Wound Healing

Pulmonary Fibrosis

Prostate Hyperplasia

Neurodermatitis

Xerophthalmia

Neurodegenerative Disease

Superficial Skin Depressions

China/US
China/US
China/US
China/US
INCI Name Granted

Technology Edge
Synergistic multi-protein engineering


Breakthrough viral vector modification strategy allowing various administration methods to meet broader clinical scenarios

Targeted delivery

Breakthrough viral vector modification strategy allowing various administration methods to meet broader clinical scenarios

Streamlined Drug Discovery

Breakthrough viral vector modification strategy allowing various administration methods to meet broader clinical scenarios

A company focusing on developing novel
drug delivery vector technology

Phone:0512-66202028

Address:Wuzhong Biology Medical Company Industrial Park Phase 3 Block A2, Guoxiang Street, Wuzhong District, Suzhou, China

Copyright © 2014-2022 IMMVIRA CO.,LTD All Rights Reserved 粤ICP备17163742号-6